CLINICAL_TRIALS
trial_result
· 2018-07-16
Clinical Trial Update: A Study of LY2584702 in Solid Tumors [Phase 1]
Summary
Phase 1 clinical trial of LY2584702 in solid tumors has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-07-16